Daldrup & Söhne AG
- WKN: 783057
- ISIN: DE0007830572
- Land: Deutschland
Nachricht vom 30.09.2021 | 06:55
Daldrup & Söhne AG increases EBIT result in H1 2021
DGAP-News: Daldrup & Söhne AG
/ Key word(s): Half Year Results
Daldrup & Söhne AG increases EBIT result in H1 2021
- Total output of 22.9 million euros at previous year's level
- EBIT of 611 TEUR 11 percent higher
- Order situation satisfactory, orders on hand at 28 million euros
- Solid equity ratio of 49.1 % (previous year 47.3 %)
- Wolfgang Bosbach elected member of the supervisory board at the annual general meeting
- Group forecast 2021 confirmed: total operating performance of around 43 million euros, operating profit margin (EBIT margin) of 2 % to 4 % of total operating performance
Oberhaching / Ascheberg, 30 September 2021 - In the first half of 2021, the drilling technology and geothermal specialist Daldrup & Söhne AG (ISIN DE0007830572) achieved a total output of 22.9 million euros (previous year 23.2 million euros) at group level, which was at the same level as in the same period of the previous year. The Group's half-year earnings before interest, taxes, depreciation and amortisation (EBITDA) as at 30 June 2021 improved slightly to €1.8 million (€1.7 million). At the operating level, the Group again achieved a positive result (EBIT) of EUR 611 thousand (EUR 549 thousand), an increase of around 11 percent. The group's half-year net income (EAT) amounted to 0.4 million euros (0.1 million euros).
The renewed positive development in the Group in the first half of 2021 is, on the one hand, the result of a vital drilling business in all business areas and well-filled order books. On the other hand, the relieving effects of the sale of the Geysir Europe Group, which was completed in January 2020, are clearly evident. Thus, despite the unchanged lively order situation, the company again reduced liabilities by EUR 1.4 million as planned. Almost EUR 600 thousand was invested in the core business for new drilling rigs. The company is thus increasing the efficiency of its drilling activities - also against the background of continuing scarce personnel resources. The goal is to further improve the earnings situation and balance sheet ratios with targeted investments and a bundle of other measures.
Commenting on the half-year results, Andreas Tönies, Spokesman of the Management Board, says: "Daldrup & Söhne AG is focusing its operating resources entirely on its core business with visible and measurable success. With further investments and the acquisition of lucrative orders, we want to further strengthen our earning power. In the medium term, the EBIT margin should be well above 5 percent. We are receiving tailwind from an unbroken brisk demand for exploratory drilling and drilling for geothermal power and heat projects in the DACH region. Thus, further geothermal projects in the Molasse Basin around Munich, in Munich itself, in the North German Plain, in Switzerland and in the Netherlands are in the starting blocks. The heat turnaround in particular secures an economically lucrative, structural growth market for geothermal energy in the medium term."
Wolfgang Bosbach elected member of the Supervisory Board
Wolfgang Bosbach (69) was a member of the German Bundestag for over 20 years. From February 2000 to November 2009, he was deputy chairman of the CDU parliamentary group in the Bundestag, and from November 2009 to September 2015, he was chairman of the parliamentary interior committee. In addition to his legal expertise, Wolfgang Bosbach has an active network in politics and business.
Order backlog of 28 million euros ensures capacity utilisation until well into 2022
Board of Management confirms forecast for the 2021 financial year
About Daldrup & Söhne AG
The shares of Daldrup & Söhne AG are listed in the Scale (sub-segment in the open market of the Frankfurt Stock Exchange).
Press & Investor Relations contact
|Company:||Daldrup & Söhne AG|
|Phone:||+49 (0) 89 / 45 24 37 920|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1236983|
|End of News||DGAP News Service|
Daldrup & Söhne AG receives further order from ...
Daldrup & Söhne AG increases EBIT result in H ...
Daldrup & Söhne AG erhält fünften Auftrag für ...
Daldrup & Söhne AG receives order to sink a ge ...
Daldrup & Söhne AG with operationally successf ...
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
30. November 15:30 Buffetts Milliarden-Wette: Nubank-IPO kleiner als erwartet
30. November 16:04 Deutsche Telekom: Droht hier ein neues Problem?
30. November 16:17 Global Fashion Group: Aktie mit Grusel-Chart – gibt es noch Hoffnung?
30. November 16:22 Die Nel-Aktie? Ein Kauf!
30. November 17:25 DAX: Powell und Omikron sorgen für kräftigen Gegenwind
News im Fokus
Vonovia SE: Vorstandsmitglieder von Vonovia werden ihre Bezugsrechte ausüben
30. November 2021, 16:02
Capital Markets Day
08. Dezember 2021
Original-Research: clearvise AG (von First Berlin Equity Research GmbH): Buy
30. November 2021